Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)

Aclaris Therapeutics (ACRS) has 2 years of Inventory data on record, last reported at $189000.0 in Q3 2019.

  • For Q3 2019, Inventory fell 81.9% year-over-year to $189000.0; the TTM value through Sep 2019 reached $189000.0, down 81.9%, while the annual FY2018 figure was $791000.0, N/A changed from the prior year.
  • Inventory reached $189000.0 in Q3 2019 per ACRS's latest filing, up from $185000.0 in the prior quarter.
  • Across five years, Inventory topped out at $1.0 million in Q3 2018 and bottomed at $185000.0 in Q2 2019.